{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:52:38Z","timestamp":1781725958921,"version":"3.54.5"},"reference-count":12,"publisher":"Norwegian Medical Association","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.20.0146","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T04:42:58Z","timestamp":1603082578000},"source":"Crossref","is-referenced-by-count":2,"title":["Ciprofloxacin usage at a local hospital"],"prefix":"10.4045","volume":"140","author":[{"given":"Vigdis","family":"Andreassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Waagsb\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4890-7555","authenticated-orcid":false,"given":"Hege Salvesen","family":"Blix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"ref=1","unstructured":"Legemiddelforbruk i Norge 1988\u20132018. Grossistbasert legemiddelstatistikk. Oslo: Folkehelseinstituttet, 2019."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Drlica\u00a0K, Malik\u00a0M, Kerns\u00a0RJ et al. Quinolone-mediated bacterial death. Antimicrob Agents Chemother 2008; 52: 385\u201392. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17724149&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1128%2FAAC.01617-06","DOI":"10.1128\/AAC.01617-06"},{"key":"ref=3","unstructured":"Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. Troms\u00f8\/Oslo: NORM, Veterin\u00e6rinstituttet, Folkehelseinstituttet, 2019."},{"key":"ref=4","unstructured":"Helsedirektoratet. Nasjonal faglig retningslinje: Antibiotika i sykehus. https:\/\/www.helsedirektoratet.no\/retningslinjer\/antibiotika-i-sykehus Lest 21.6.2020."},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Fagan\u00a0M, Skotheim\u00a0SB. Fluorokinolonbruk i sykehjem. Tidsskr Nor Legeforen 2010; 130: 2022\u20134. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20967041&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4045%2Ftidsskr.09.0560","DOI":"10.4045\/tidsskr.09.0560"},{"key":"ref=6","unstructured":"Surveillance of antimicrobial resistance in Europe \u2013 Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-net) 2017. Stockholm: European Centre for Disease Prevention and Control, 2018. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AMR%202017_Cover%2BInner-web_v3.pdf Lest 21.6.2020."},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Roger\u00a0PM, Montera\u00a0E, Lesselingue\u00a0D et al. Risk factors for unnecessary antibiotic therapy: A major role for clinical management. Clin Infect Dis 2019; 69: 466\u201372. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30403779&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093%2Fcid%2Fciy921","DOI":"10.1093\/cid\/ciy921"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Sacco\u00a0KA, Bates\u00a0A, Brigham\u00a0TJ et al. Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis. Allergy 2017; 72: 1288\u201396. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=28370003&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fall.13168","DOI":"10.1111\/all.13168"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Shenoy\u00a0ES, Macy\u00a0E, Rowe\u00a0T et al. Evaluation and management of penicillin allergy: A review. JAMA 2019; 321: 188\u201399. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=30644987&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Fjama.2018.19283","DOI":"10.1001\/jama.2018.19283"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Tanne\u00a0JH. FDA adds \"black box\" warning label to fluoroquinolone antibiotics. BMJ 2008; 337: a816. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18632714&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fbmj.a816","DOI":"10.1136\/bmj.a816"},{"key":"ref=11","unstructured":"European Medicines Agency. Fluoroquinolone and quinolone antibiotics: PRAC recommends restrictions on use. EMA\/668915\/2018. https:\/\/www.ema.europa.eu\/en\/documents\/press-release\/fluoroquinolone-quinolone-antibiotics-prac-recommends-restrictions-use_en.pdf Lest 21.6.2020."},{"key":"ref=12","unstructured":"Sykehusapotekenes legemiddelstatistikk: Antibiotikakuben 2019."}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Bruk av ciprofloksacin ved et lokalsykehus"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T07:53:12Z","timestamp":1781682792000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2020\/10\/kort-rapport\/bruk-av-ciprofloksacin-ved-et-lokalsykehus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":12,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2020,10,13]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.20.0146","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]}}}